TY  - CHAP
M1  - Book, Section
TI  - HIV-Related Malignancies
A1  - Dezube, Bruce J.
A2  - Boyiadzis, Michael M.
A2  - Frame, James N.
A2  - Kohler, David R.
A2  - Fojo, Tito
Y1  - 2016
N1  - 
T2  - Hematology-Oncology Therapy, 2e
AB  - Epidemiology  of  KSTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiology  of  KSIncidence/100,000United  StatesMales:2.1Females:0.11AfricaMales:39.3Females:21.8Stage  at  Presentation  in  HAART  Era  (Based  on  ACTG✫  Modified  TIS  Staging)Poor  risk:25%Good  risk:75%✫ACTG:  AIDS  Clinical  Trials  GroupDeaths  caused  by  AIDS  since  advent  of  HAART  have  decreased  by  more  than  50%  Nasti  G  et  al.  J  Clin  Oncol  2003;21:2876–2882  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - hemonc.mhmedical.com/content.aspx?aid=1160299663
ER  -